The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic methods for metabolic dysfunction–associated steatohepatitis (MASH).
The Vietnam lipid market, estimated at USD 124.32 million in 2024, is projected to grow to USD 189.44 million by 2033, exhibiting a CAGR of 7.23% during the forecast period. This growth is primarily ...
The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Investigators found that lipid metabolism disruptions spark T-cell dysfunction in patients with chronic lymphocytic leukemia.
Scientists have identified the Plvap gene as a key regulator of metabolism during fasting. Disabling it in mice prevented the ...
Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...
Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and ...
Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...
Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their specific roles in the progression of disease remain unknown. To address this gap ...
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback